Synthorx (THOR) Return on Equity ROE from the third quarter 2019 to third quarter 2018 and annually, average high and low, overall ranking from Sep 30 2019 to Jun 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Synthorx, Inc.  (NASDAQ: THOR)

Synthorx's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Synthorx in the third quarter 2019?
Synthorx, Inc. recorded a cumulative net loss of $-58 million during 12 months ending in the third quarter 2019, resulting in a negative return on equity (ROE) of -34.25%.

Within the Major Pharmaceutical Preparations industry 70 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2019 from 2436 to 2903.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter
Y / Y Equity Change -77.66 % -74.71 % -72.47 % -71.74 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -58 -49 -39 -15 18
Return On Equity (TTM) -34.25 % -16.47 % -9.33 % -2.84 % 2.73 %
THOR's Total Ranking # 2903 # 2436 # 1907 # #
Equity (TTM) in Millions 152 163 174 184 680
Seq. Equity Change -6.87 % -6.32 % -5.52 % -72.9 % 5.41 %
Seq. Net Income Change - - - - -

Back to THOR Management Effectiveness >> THOR's 5 Years Annual ROE >> Compare THOR ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 71
Sector # 222
Overall # 2903

Return On Equity Statistics
High Average Low
9.61 %
5.15 %
-7.59 %
(Jun 28 2014)   (Sep 30 2019)





THOR Annual Return On Equity (Jan 03 2015)
2014		 (Dec 28 2013)
2013		 (Dec 29 2012)
2012		 (Dec 31 2011)
2011		 (Jan 03 2009)
2010
Total Equity in Millions 633 667 597 584 525
Y / Y Equity Change -5.08 % 11.72 % 2.1 % 11.3 % -
Net Income in Millions 50 73 56 72 18
Y / Y Net Income Change -31.28 % 30.56 % -21.5 % 290.29 % -
Return On Equity 7.96 % 11 % 9.41 % 12.24 % 3.49 %

Back to THOR Management Effectiveness >> THOR's 5 Years Annual ROE >> Compare THOR ROE to its Competitors




Annual Roe Comment
In 2014 ROE decreased compared to the previous year to 7.96 %, due to deterioration of net income.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
THOR's' Return on Equity at Yahoo Finance
THOR's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for THOR's Competitors
Subscribers only: Roe for Synthorx's Suppliers
Subscribers only: Return On Equity for THOR's Customers




Companies with similar Return On Equity at Sep 30 2019, within Healthcare Sector ROE

Date modified: 2026-09-08T15:09:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.